Dr Celia Hart

Investment Director at CEA Investissement

Celia has more than 15 years’ experience in the chemical and biotechnology sector. She received her PhD in protein engineering from Oxford University (UK). Celia then worked in the UK Biotechnology industry at Cambridge Antibody Technology (now Medimmune) where she was the Head of Lead Optimisation and led the R&D development of several therapeutic antibodies. Following an MBA at the Grenoble School of Business (France) she has been involved in assessing new business opportunities built on strong science at leading institutions (ESRF, CEA). She joined CEA Investissement (Grenoble), one of the leading seed investment funds in France, in 2005 and is now Investment Director in charge of the life science sector.  She is often involved in setting up new companies working together with French innovation agencies (incubators, innovation clusters, technology transfer offices, etc.). She serves on the Board of several companies including Cytoo, Fermentalg, ImmunId and Eviagenics.